Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission-Reference-Cited by-同舟云学术

Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission

Published:2022-07 Issue:7 Volume:28 Page:374.e1-374.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Klyuchnikov Evgeny^ORCID,Badbaran Anita,Massoud Radwan,Fritzsche-Friedland Ulrike,Freiberger Petra,Ayuk Francis,Wolschke Christine,Bacher Ulrike^ORCID,Kröger Nicolaus

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference52 articles.

1. Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation;Grimm;Blood Adv,2020

2. Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial;Platzbecker;Lancet Oncol,2018

3. Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time;Tang;Biol Blood Marrow Transplant,2014

4. Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia;Wiedemann;Exp Hematol,2010

5. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective;Bader;Bone Marrow Transplant,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients;Transplantation and Cellular Therapy;2024-07

2. Monitoring Measurable/Minimal Residual Disease in Acute Myeloid Leukemia: Multiparametric Flow Cytometry-Based Approach;Indian Journal of Medical and Paediatric Oncology;2023-11-27

3. Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation;Leukemia;2023-10-25

4. Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS;Blood Advances;2023-07-17

5. MRD-directed and risk-adapted individualized stratified treatment of AML;Chinese Journal of Cancer Research;2023